References
- Pinkus H, Mehregan AH. Epidermotropic Eccrine Carcinoma. A Case Combining Features of Eccrine Poroma and Paget's Dermatosis. Arch Dermatol. 1963;88:597-606. https://doi.org/10.1001/archderm.1963.01590230105015
- Kim JW, Oh DJ, Kang MS, Lee D, Hwang SW, Park SW. A case of metastatic eccrine porocarcinoma. Acta Derm Venerel. 2007; 87:550-552. https://doi.org/10.2340/00015555-0310
- Girishkumar H, Kamineni S, Hwang RR, Levy J, Sadler R. Eccrine porocarcinoma. Dermatol Surg. 1997;23:583-584. https://doi.org/10.1016/S1076-0512(97)00135-0
- Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma(malignant eccrine poroma): A clinicopathologic study of 69 cases. Am J Surg Pathol. 2001;25:710- 720. https://doi.org/10.1097/00000478-200106000-00002
- Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: Report of a case and review of the literature. J Am Acad Dermatol. 1996;35:860-864. https://doi.org/10.1016/S0190-9622(96)90105-X
- Ishikawa K. Malignant hidroacanthoma simplex. Arch Dermatol. 1971;104:529-532. https://doi.org/10.1001/archderm.1971.04000230071012
- Shiohara J, Koga H, Uhara H, Takata M, Saida T. Eccrine porocarcinoma: Clinical and pathological studies of 12 cases. J Dermatol. 2007;34:516-522. https://doi.org/10.1111/j.1346-8138.2007.00324.x
- Grimme H, Petres A, Bergen E, Wiemers S, Schopf E, Vanscheidt W. Metastasizing porocarcinoma of the head with lethal outcome. Dermatology. 1999;198:298-300. https://doi.org/10.1159/000018135
- Nouri K, Rivas MP, Pedroso F, Bhatia R, Civantos F. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinomas of the head and neck. Arch Dermatol. 2004;140:1284. https://doi.org/10.1001/archderm.140.10.1284-b
- Vaz Salgado MA, Garcia CG, Lopez Martin JA, Guerra E, Benito A, Sepulveda JM, et al. Porocarcinoma: Clinical evolution. Dermatol Surg. 2010;36(2):264-267. https://doi.org/10.1111/j.1524-4725.2009.01412.x
- Pernia LR, Guzman-Stein G, Miller HL. Surgical treatment of an aggressive metastasized eccrine poroma. Ann Plast Surg. 1993;30:257-259. https://doi.org/10.1097/00000637-199303000-00010
- Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: Response to docetaxel(Taxotere) chemotherapy. Ann Oncol. 2001;12:411-414. https://doi.org/10.1023/A:1011196615177
- Piedbois P, Breau JL, Morere JF, Israel L. Sweat gland carcinoma with bone and visceral metastasis: Prolonged complete remission lasting 16 months as a result of chemotherapy. Cancer. 1987;60:170-172. https://doi.org/10.1002/1097-0142(19870715)60:2<170::AID-CNCR2820600208>3.0.CO;2-R
- Gonzalez-Lopez MA, Vazquez-Lopez F, Soler T, Gomez-Diez S, Garcia YH, Manjon JA, et al. Metastatic eccrine porocarcinoma: A 5.6-year follow-up study of a patient treated with a combined therapeutic protocol. Dermatol Surg. 2003;29:1227-1232. https://doi.org/10.1111/j.1524-4725.2003.29393.x
- Gutermuth J, Audring H, Voit C, Trefzer U, Haas N. Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatol Venereol. 2004;18:477-479. https://doi.org/10.1111/j.1468-3083.2004.00949.x
- Tlemcani K, Levine D, Smith RV, Brandwein-Gensler M, Staffenberg DA, Garg MK, et al. Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy. J Clin Oncol. 2010;28:e412-e414. https://doi.org/10.1200/JCO.2009.26.1891
- Yamashita H, Kadono T, Tamaki K, Nakagawa K. Interesting response to concurrent chemoradiation in metastatic eccrine porocarcinoma. J Dermatol. 2008;35:606-607. https://doi.org/10.1111/j.1346-8138.2008.00533.x